Inactive Instrument
Probi AB Share Price
Stocks
PROB
SE0001280355
Pharmaceuticals
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Anita Johansen
CEO | Chief Executive Officer | 54 | 07/12/2022 |
Johan Flink
DFI | Director of Finance/CFO | 49 | 31/07/2025 |
James Henson
COO | Chief Operating Officer | 39 | 31/12/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Jörn Andreas
BRD | Director/Board Member | 45 | 31/12/2013 |
| Chairman | 62 | 31/03/2015 | |
| Director/Board Member | 64 | 03/05/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/02/25 | Buy | Company | 142,586 | 1.2514% | ||
| 21/01/25 | Buy | Company | 2,840,101 | 24.9260% | ||
| 28/11/24 | Buy | Company | 33,086 | 0.2904% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.29% | - | - | 33.68M | |
| +0.73% | -5.64% | +58.34% | +108.95% | 1,031B | |
| +1.03% | -1.60% | +50.95% | +67.49% | 641B | |
| +0.95% | -2.60% | +22.15% | +74.68% | 453B | |
| -1.50% | -7.04% | +33.55% | +33.94% | 349B | |
| +6.25% | +2.04% | +28.97% | +46.57% | 290B | |
| -0.07% | -4.12% | +0.95% | +11.79% | 252B | |
| +0.33% | -2.31% | +50.57% | +68.29% | 232B | |
| +0.51% | -4.52% | -19.50% | -54.83% | 201B | |
| +1.24% | -0.28% | +31.63% | +93.56% | 181B | |
| Average | +0.84% | -2.98% | +28.62% | +50.05% | 403.31B | |
| Weighted average by Cap. | +0.88% | -3.97% | +37.67% | +65.99% |
Employees
-
Sector
Pharmaceuticals
